CHF appreciates the opportunity to provide a comment in response to proposed changes to a number of definitions and the scope of the medical device regulatory framework in Australia.
At the heart of CHF’s policy agenda is patient-centred care. Our responses to the TGA’s consultation questions have been formed with a patient-centred approach in mind.

Read the submission here

Publication type: 
Publish date: 
Monday, March 4, 2019
Consumers Health Forum